ZA200403069B - Alpha2delta ligands to treat tinnitus. - Google Patents
Alpha2delta ligands to treat tinnitus. Download PDFInfo
- Publication number
- ZA200403069B ZA200403069B ZA200403069A ZA200403069A ZA200403069B ZA 200403069 B ZA200403069 B ZA 200403069B ZA 200403069 A ZA200403069 A ZA 200403069A ZA 200403069 A ZA200403069 A ZA 200403069A ZA 200403069 B ZA200403069 B ZA 200403069B
- Authority
- ZA
- South Africa
- Prior art keywords
- aminomethyl
- methyl
- acid
- acetic acid
- integer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35363202P | 2002-01-31 | 2002-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200403069B true ZA200403069B (en) | 2005-04-22 |
Family
ID=27663234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200403069A ZA200403069B (en) | 2002-01-31 | 2004-04-22 | Alpha2delta ligands to treat tinnitus. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7026505B2 (enExample) |
| EP (1) | EP1469841A1 (enExample) |
| JP (1) | JP2005521664A (enExample) |
| KR (1) | KR20040081478A (enExample) |
| CN (1) | CN1625393A (enExample) |
| AU (1) | AU2003201716B2 (enExample) |
| BR (1) | BR0307411A (enExample) |
| CA (1) | CA2474000A1 (enExample) |
| CL (1) | CL2008000613A1 (enExample) |
| IL (1) | IL162028A0 (enExample) |
| MX (1) | MXPA04004105A (enExample) |
| NZ (1) | NZ532624A (enExample) |
| PL (1) | PL371944A1 (enExample) |
| TW (1) | TW200306177A (enExample) |
| WO (1) | WO2003063845A1 (enExample) |
| ZA (1) | ZA200403069B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU714980B2 (en) | 1996-07-24 | 2000-01-13 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| CA2518218A1 (en) | 2003-03-07 | 2004-09-16 | Warner-Lambert Company Llc | Tetrazole and oxadiazolone substituted .beta.-amino acid derivatives |
| WO2004096139A2 (en) | 2003-04-24 | 2004-11-11 | Incyte Corporation | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| JP2006526017A (ja) * | 2003-05-14 | 2006-11-16 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
| US7727978B2 (en) | 2006-08-24 | 2010-06-01 | Bristol-Myers Squibb Company | Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| CN101506140B (zh) * | 2006-08-24 | 2014-06-18 | 百时美施贵宝公司 | 环状11β-羟类固醇脱氢酶Ⅰ型抑制剂 |
| MX2009005114A (es) * | 2006-11-14 | 2009-07-16 | Xenoport Inc | Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. |
| EP2101752A1 (en) * | 2006-12-08 | 2009-09-23 | Xenoport, Inc. | Use of prodrugs of gaba analogs for treating diseases |
| ITMI20071492A1 (it) | 2007-07-24 | 2009-01-25 | S I I T Srl Servizio Internazi | "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba" |
| US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| CN101260063B (zh) * | 2008-03-21 | 2013-06-19 | 北京润德康医药技术有限公司 | γ-氨基丁酸衍生物及其制备方法 |
| SG157299A1 (en) | 2008-05-09 | 2009-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
| CN111718379A (zh) * | 2019-03-19 | 2020-09-29 | 海南长安国际制药有限公司 | 具有l1和l2结构的铂类物质及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| DE69737719D1 (de) * | 1996-10-23 | 2007-06-21 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
| CN1210268C (zh) * | 1997-12-16 | 2005-07-13 | 沃尼尔·朗伯公司 | ((环)烷基取代的)－γ－氨基丁酸衍生物(=GABA类似物),其制备和在治疗神经病中的用途 |
| TR200001795T2 (tr) * | 1997-12-16 | 2000-11-21 | Warner-Lambert Company | 1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı. |
| CA2304967C (en) * | 1997-12-16 | 2005-06-14 | Warner-Lambert Company | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| EP1082306A1 (en) | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| GB9821179D0 (en) * | 1998-09-30 | 1998-11-25 | Merck Sharp & Dohme | Therapeutic use |
| KR100694735B1 (ko) * | 1999-06-10 | 2007-03-14 | 워너-램버트 캄파니 엘엘씨 | 일치환 및 이치환된 3-프로필 감마-아미노부티르산 |
| HN2000000224A (es) * | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| US6620829B2 (en) * | 2000-10-17 | 2003-09-16 | Warner-Lambert Company | Method of treating noninflammatory cartilage damage |
-
2003
- 2003-01-20 KR KR10-2004-7011809A patent/KR20040081478A/ko not_active Ceased
- 2003-01-20 CA CA002474000A patent/CA2474000A1/en not_active Abandoned
- 2003-01-20 WO PCT/IB2003/000232 patent/WO2003063845A1/en not_active Ceased
- 2003-01-20 MX MXPA04004105A patent/MXPA04004105A/es active IP Right Grant
- 2003-01-20 IL IL16202803A patent/IL162028A0/xx unknown
- 2003-01-20 BR BR0307411-0A patent/BR0307411A/pt not_active IP Right Cessation
- 2003-01-20 EP EP03700417A patent/EP1469841A1/en not_active Ceased
- 2003-01-20 PL PL03371944A patent/PL371944A1/xx not_active Application Discontinuation
- 2003-01-20 NZ NZ532624A patent/NZ532624A/en unknown
- 2003-01-20 CN CNA038031388A patent/CN1625393A/zh active Pending
- 2003-01-20 JP JP2003563539A patent/JP2005521664A/ja not_active Withdrawn
- 2003-01-20 AU AU2003201716A patent/AU2003201716B2/en not_active Ceased
- 2003-01-29 US US10/353,367 patent/US7026505B2/en not_active Expired - Fee Related
- 2003-01-30 TW TW092102235A patent/TW200306177A/zh unknown
-
2004
- 2004-04-22 ZA ZA200403069A patent/ZA200403069B/en unknown
-
2005
- 2005-12-21 US US11/314,126 patent/US7138542B2/en not_active Expired - Fee Related
-
2008
- 2008-02-28 CL CL2008000613A patent/CL2008000613A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0307411A (pt) | 2004-12-07 |
| KR20040081478A (ko) | 2004-09-21 |
| CL2008000613A1 (es) | 2008-11-07 |
| US7026505B2 (en) | 2006-04-11 |
| CN1625393A (zh) | 2005-06-08 |
| TW200306177A (en) | 2003-11-16 |
| MXPA04004105A (es) | 2004-11-29 |
| US20060100281A1 (en) | 2006-05-11 |
| IL162028A0 (en) | 2005-11-20 |
| AU2003201716B2 (en) | 2008-04-17 |
| US20030176504A1 (en) | 2003-09-18 |
| PL371944A1 (en) | 2005-07-11 |
| JP2005521664A (ja) | 2005-07-21 |
| EP1469841A1 (en) | 2004-10-27 |
| NZ532624A (en) | 2007-05-31 |
| WO2003063845A1 (en) | 2003-08-07 |
| US7138542B2 (en) | 2006-11-21 |
| CA2474000A1 (en) | 2003-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200403069B (en) | Alpha2delta ligands to treat tinnitus. | |
| JP2000515486A (ja) | アダマンタン誘導体の内耳炎治療向け使用 | |
| EP2054047B1 (en) | Methods for treating acute acoustic trauma | |
| US6306910B1 (en) | Use of Gaba-analogues for treating insomnia | |
| US20070021352A1 (en) | Prevention and treatment of hearing disorders | |
| ZA200601551B (en) | Combination comprising an Alpha-2 Delta ligand and SSRI and/or SNRI for treatment of depression and anxiety disorders | |
| EP3004353B1 (en) | Bumetanide for treating neurodegenerative diseases with parkinsonian syndromes | |
| KR100823668B1 (ko) | 신경성 통증 치료 및 예방약 | |
| JP2012148995A (ja) | 難聴疾患の予防又は治療剤 | |
| WO2009089366A2 (en) | Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators | |
| EP1171114A1 (en) | Method for the treatment of incontinence | |
| JPH0116809B2 (enExample) | ||
| EP1296665B1 (en) | Analgesic and anti-inflammatory compositions containing celecoxib and ibuprofen | |
| WO1992002221A1 (en) | Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one | |
| RS64304B1 (sr) | Betahistin, ili njegova farmaceutski prihvatljiva so, i inhibitor monoaminske oksidaze, za upotrebu u lečenju ili prevenciji jednog ili više simptoma vrtoglavice kod subjekta | |
| ZA200409848B (en) | Method treating attention deficit hyperactivity disorder | |
| HUP0202339A2 (hu) | Kortizol antagonisták alkalmazása szívelégtelenség kezelésére | |
| AU2003213084B2 (en) | Treatment of ophthalmic disorders using urea and urea derivatives | |
| EP4301351A1 (en) | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures | |
| Heyka et al. | Control of hypertension in patients with chronic renal failure | |
| US20040018151A1 (en) | Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods | |
| IL320636A (en) | Benzaldehyde compounds with destabilizing effects on polymers for the treatment of sickle cell disease | |
| WO2022037006A1 (zh) | 一种止痛止痒药物组合物及其应用方法 | |
| US20130210784A1 (en) | Combinations and methods for treating non age-related hearing impairment in a subject | |
| Riga et al. | Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity |